期刊文献+

表达A3C的HBV载体质粒抑制HBV的研究

Inhibitory effect of a HBV vector plasmid expressing A3C on HBV replication
下载PDF
导出
摘要 目的观察表达人类载脂蛋白B mRNA编辑酶催化多肽3C(A3C)的复制缺损型HBV载体质粒抑制乙型肝炎病毒(HBV)的作用。方法利用PCR技术和基因重组方法构建表达A3C和人绿色荧光蛋白(hrGFP)的HBV载体质粒pCH-LJ3-A3C、pCH-LJ3-hrGFP,分别与野生型HBV质粒pCH-3093共转染HepG2细胞,提取细胞裂解液及细胞培养上清液中病毒颗粒DNA进行Southern blot检测;提取细胞裂解液中核心蛋白相关的HBV DNA,PCR扩增,克隆,测序。结果pCH-LJ3-A3C对细胞浆及细胞培养上清液中病毒颗粒DNA具有抑制作用,使细胞浆内HBV DNA减少31%,使上清液中子代病毒颗粒HBV DNA减少40%;对HBV DNA具有编辑作用,50个克隆测定HBV DNA序列,36克隆出现G-A突变,G-A突变总数量982位点。结论pCH-LJ3-A3C可以抑制HBV复制,pCH-LJ3-A3C对HBV DNA的编辑作用是其发挥作用的主要原因,pCH-LJ3-A3C可以作为一种新型的抗病毒制剂治疗HBV感染。 Objective To observe the inhibitory effect of a replication-defective hepatitis B virus (HBV) vector plasmid expressing A3C on HBV replication in vitro. Methods The HBV vector plasmisd pCH-LJ3-A3C and pCH-LJ3-hrGFP expressing A3C and hrGFP were constructed using PCR and gene recombination technique. The two recombinant plasmids were separately cotranfected into HepG2 cells along with the wild-type HBV plasmid pCH-3093. The HBV DNA in the cell cytoplasmic lysates and in the cell culture supematant was extracted for Southern blotting, and the nucleocapsid-associated HBV DNA were amplified by PCR, cloned and sequenced. Results pCH-LJ3-A3C showed obvious inhibitory effect on HBV DNA in the cytoplasmic lysates and cell culture supematant, causing a reduction of the HBV DNA by 31% and 40%, respectively. The pCH-LJ3-A3C plasmid was capable of editing the HBV DNA. Among the 50 sequenced clones, 36 clones had G-A mutations, with a total of 982 such mutations. Conclusion pCH-LJ3-A3C can inhibit the replication of HBV primarily by editing HBV DNA. The pCH-LJ3-A3C plasmid may serve as a new antiviral agent against human HBV infection.
作者 李东 王宇明
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第10期2044-2047,2050,共5页 Journal of Southern Medical University
关键词 乙型肝炎病毒 重组乙肝病毒载体 基因治疗 HEPG2细胞 载脂蛋白B mRNA编辑酶催化多肽 3C hepatitis B virus recombinant HBV vector HepG2 cell line apolipoprotain B mRNA-editing enzyme catalytic polypeptide-like 3C
  • 相关文献

参考文献16

  • 1Ganem D, Prince A. Hepatitis B virus infection -natural history and clinical consequences [J]. N Engl J Med, 2004, 350:1118-29.
  • 2Bourara K, Liegler TJ, Grant RM. Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1 [J]. PLoS Pathog, 2007, 3 (10): 1477-85.
  • 3Langlois MA, Beale RC, Conticello SG, et al. Mutational comparison of the single-domainedAPOBEC3C and double- domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities [J ]. Nucleic Acids Res, 2005, 33: 1913-23.
  • 4孙殿兴,胡大荣,邬光惠.抗乙型肝炎病毒分子治疗新策略[J].中华肝脏病杂志,2001,9(5):317-318. 被引量:8
  • 5Jarmuz A, hester A, Baylls J, et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22[J].Genomics, 2002, 79: 285-96.
  • 6Yu Q, Chen D, Ktinig R, et al. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication [J]. J Biol Chem, 2004, 279: 53379-86.
  • 7Gunther S, Sommer G, Plikat U, et al. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-A hypermutation[J]. Virology, 1997, 235: 104-8.
  • 8Baumert TF, R6sler C, Malim MH, et al. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C [J]. Hepatology, 2007, 46: 682-9.
  • 9Bishop KN, Holmes RK, Sheehy AM, et al. APOBEC-mediated editing of viral RNA[J]. Science, 2004, 305: 645.
  • 10Holmes RK, Malim MH, Bishop KN. APOBEC-mediated viral restriction: not simply editing [J]? Trends Biochem Sci, 2007, 32 (3): 118-28.

二级参考文献4

  • 1Protzer U,Proc Natl Acad Sci USA,1999年,96卷,10818页
  • 2Smith R M,Semin Liver Dis,1999年,19卷,83页
  • 3Xiao W,J Virol,1998年,72卷,10222页
  • 4Zu Putlitz J,J Virol,1999年,73卷,5381页

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部